Cytokine release syndrome complicated with severe rashes induced by nivolumab plus ipilimumab therapy in a patient with non‐small cell lung cancer: A case report
Thoracic Cancer · 2023
DOI: 10.1111/1759-7714.15015 ↗Kurz gefasst
Fallbericht in der Zeitschrift Thoracic Cancer, 2023. Verfasst von Toshiharu Tsutsui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lung Cancer and Respiratory Disease Center, Yamanashi Prefectural Central Hospital, Kofu-shi, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Antineoplastic Agents, Immunological, Lung Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Cytokine release syndrome (CRS) is a severe and life‐threatening toxicity typically reported in chimeric antigen receptor T cell therapy and is rarely reported in immune checkpoint inhibitor (ICI) therapy. This study reports the case of a 75‐year‐old Japanese woman who received nivolumab plus ipilimumab therapy for the postoperative recurrence of non‐small cell lung cancer. She was admitted to our hospital with fever, hypotension, hepatic disorder, and thrombocytopenia. We observed slight skin rashes on her neck on admission, which spread rapidly across her body within a few days. We diagnosed CRS complicated by severe rashes. CRS symptoms were resolved with corticosteroid therapy, and did not recur thereafter. CRS is a rare, but important, immune‐related adverse event associated with ICI therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lung Cancer and Respiratory Disease Center, Yamanashi Prefectural Central Hospital, Kofu-shi, Japan.
ORCID-Profile: Toshiharu Tsutsui, Yoshihiro Miyashita
Zitieren
APA
Tsutsui, T., Hata, K., Kawaguchi, M., Kobayashi, H., Kakizaki, Y., & Miyashita, Y. (2023). Cytokine release syndrome complicated with severe rashes induced by nivolumab plus ipilimumab therapy in a patient with non‐small cell lung cancer: A case report. Thoracic Cancer. https://doi.org/10.1111/1759-7714.15015
Vancouver
Tsutsui T, Hata K, Kawaguchi M, Kobayashi H, Kakizaki Y, Miyashita Y. Cytokine release syndrome complicated with severe rashes induced by nivolumab plus ipilimumab therapy in a patient with non‐small cell lung cancer: A case report. Thoracic Cancer. 2023. doi:10.1111/1759-7714.15015
BibTeX
@article{Tsutsui2023,
author = {Tsutsui, Toshiharu and Hata, Koki and Kawaguchi, Makoto and Kobayashi, Hiroaki and Kakizaki, Yumiko and Miyashita, Yoshihiro},
title = {Cytokine release syndrome complicated with severe rashes induced by nivolumab plus ipilimumab therapy in a patient with non‐small cell lung cancer: A case report},
journal = {Thoracic Cancer},
year = {2023},
doi = {10.1111/1759-7714.15015}
}
EUVIMED